Similar articles

• Medical management for termination of second and third trimester pregnancies: a comparison of strategies.

  De Heus R, Graziosi GC, Christiaens GC, Bruinse HW, Mol BW. De Heus R, et al. Eur J Obstet Gynecol Reprod Biol. 2004 Sep 10;116(1):16-21. doi: 10.1016/j.ejogrb.2003.12.012. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15294361
• Mifepristone and misoprostol sequential regimen side effects, complications and safety.

  Sitruk-Ware R. Sitruk-Ware R. Contraception. 2006 Jul;74(1):48-55. doi: 10.1016/j.contraception.2006.03.016. Epub 2006 May 15. Contraception. 2006. PMID: 16781261 Review.
• Unscarred uterine cervical rupture during second-trimester termination using misoprostol.

  Lee SJ, Su JM, Shen WL, Chang FM. Lee SJ, et al. Taiwan J Obstet Gynecol. 2007 Dec;46(4):445-7. doi: 10.1016/s1028-4559(08)90020-6. Taiwan J Obstet Gynecol. 2007. PMID: 18182358 No abstract available.
• Vaginal misoprostol 800 microg every 12 h for second-trimester abortion.

  Carbonell JL, Rodríguez J, Delgado E, Sánchez C, Vargas F, Valera L, Marí J, Valero F, Salvador I, Llorente M. Carbonell JL, et al. Contraception. 2004 Jul;70(1):55-60. doi: 10.1016/j.contraception.2004.01.010. Contraception. 2004. PMID: 15208053 Clinical Trial.
• Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.

  Gemzell-Danielsson K, Lalitkumar S. Gemzell-Danielsson K, et al. Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8. Reprod Health Matters. 2008. PMID: 18772097 Review.